Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henderik W Frijlink

Showing results (11-20 of 196) with videos related to

Pageof 20
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 3, 2014
Enhanced pulmonary immunization with aerosolized inactivated influenza vaccine containing delta inulin adjuvantSenthil Murugappan, Henderik W Frijlink, Nikolai Petrovsky, et al.
Plos One|July 12, 2013
Mixing time effects on the dispersion performance of adhesive mixtures for inhalationFloris Grasmeijer, Paul Hagedoorn, Henderik W Frijlink, et al.
International Journal of Pharmaceutics|September 4, 2012
Characterisation of high dose aerosols from dry powder inhalersFloris Grasmeijer, Paul Hagedoorn, Henderik W Frijlink, et al.
Journal of Pharmaceutical Sciences|October 14, 2019
Inhomogeneous Distribution of Components in Solid Protein Pharmaceuticals: Origins, Consequences, Analysis, and ResolutionsKhanh T T Nguyen, Henderik W Frijlink, Wouter L J Hinrichs
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Pharmacoeconomic review of recombinant human DNase in the management of cystic fibrosisGerrit S Zijlstra, Cornelis Boersma, Henderik W Frijlink, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 30, 2015
Can 'extrafine' dry powder aerosols improve lung deposition?Anne H de Boer, Doetie Gjaltema, Paul Hagedoorn, et al.
International Journal of Pharmaceutics|November 12, 2018
Development of novel zero-order release budesonide tablets for the treatment of ileo-colonic inflammatory bowel disease and comparison with formulations currently used in clinical practiceBahez Gareb, Gerard Dijkstra, Jos G W Kosterink, et al.
Plos One|August 23, 2013
Drug content effects on the dispersion performance of adhesive mixtures for inhalationFloris Grasmeijer, Paul Hagedoorn, Henderik W Frijlink, et al.
Respiratory Medicine|June 16, 2014
The clinical relevance of dry powder inhaler performance for drug deliveryPascal Demoly, Paul Hagedoorn, Anne H de Boer, et al.
Plos One|September 17, 2013
A user-friendly model for spray drying to aid pharmaceutical product developmentNiels Grasmeijer, Hans de Waard, Wouter L J Hinrichs, et al.
Pageof 20

Showing results (11-20 of 196) with videos related to

Sort By:
Pageof 20
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 3, 2014
Enhanced pulmonary immunization with aerosolized inactivated influenza vaccine containing delta inulin adjuvantSenthil Murugappan, Henderik W Frijlink, Nikolai Petrovsky, et al.
Plos One|July 12, 2013
Mixing time effects on the dispersion performance of adhesive mixtures for inhalationFloris Grasmeijer, Paul Hagedoorn, Henderik W Frijlink, et al.
International Journal of Pharmaceutics|September 4, 2012
Characterisation of high dose aerosols from dry powder inhalersFloris Grasmeijer, Paul Hagedoorn, Henderik W Frijlink, et al.
Journal of Pharmaceutical Sciences|October 14, 2019
Inhomogeneous Distribution of Components in Solid Protein Pharmaceuticals: Origins, Consequences, Analysis, and ResolutionsKhanh T T Nguyen, Henderik W Frijlink, Wouter L J Hinrichs
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Pharmacoeconomic review of recombinant human DNase in the management of cystic fibrosisGerrit S Zijlstra, Cornelis Boersma, Henderik W Frijlink, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 30, 2015
Can 'extrafine' dry powder aerosols improve lung deposition?Anne H de Boer, Doetie Gjaltema, Paul Hagedoorn, et al.
International Journal of Pharmaceutics|November 12, 2018
Development of novel zero-order release budesonide tablets for the treatment of ileo-colonic inflammatory bowel disease and comparison with formulations currently used in clinical practiceBahez Gareb, Gerard Dijkstra, Jos G W Kosterink, et al.
Plos One|August 23, 2013
Drug content effects on the dispersion performance of adhesive mixtures for inhalationFloris Grasmeijer, Paul Hagedoorn, Henderik W Frijlink, et al.
Respiratory Medicine|June 16, 2014
The clinical relevance of dry powder inhaler performance for drug deliveryPascal Demoly, Paul Hagedoorn, Anne H de Boer, et al.
Plos One|September 17, 2013
A user-friendly model for spray drying to aid pharmaceutical product developmentNiels Grasmeijer, Hans de Waard, Wouter L J Hinrichs, et al.
Pageof 20